Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$81.22$171.74
1-Month Range
Month up 3.9%
$150.83$165.78
Daily Price Range
Day up 1.3%
$159.61$163.29
Volume
vs 2M avg
4400102M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$17.9B
Short % of Float—
Employees—
Sales$2,856M
Shares Outstanding111,586,401
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.rvty.com
Revvity Inc — Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular d….· via yahoo
Warnings
1 signal
Live
- ROE below 5% (3.5%)
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
63
Growth
78
Quality
45
Sentiment
95
Insider Sent.
0
Piotroski F
8
Altman Z
3.3
Consensus rating unavailable — no analyst coverage on file for RVTY.
Price targets unavailable — no 12-month targets on file for RVTY.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on RVTY, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:08 PM UTC